Treatment Results
|
|
| Description: |
| Patients: This Phase I study involved 21 patients with a variety of different solid tumors. Two of the 21 patients had mesothelioma.
Treatment: The treatment consisted of the administration of an extract (Ecteinascidin 743 (ET-743) a cytotoxic tetrahydroisoquinoline alkaloid) from a marine animal called a tunicate (Ecteinascidia turbinate). Toxicity: Grade 3-4 toxicities included hematologic, transaminitis, cardiac, rhabdomyolysis, renal, fatigue and nausea/vomiting. Results: One of the two mesothelioma patients had a 41% reduction by CT scan in the size of disease in the mediastinal lymph nodes and a pulmonary nodule. This patient’s cancer ultimately grew. Overall survival was not discussed. Support: Research support came from PharmaMar S.A. This company markets ET-743. Correspondence: David P. Ryan, MD |
“My Name is Paul Kraus and I Have Survived Mesothelioma for Nearly 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."